Legal Representation
Attorney
Lawrence K. Nodine
USPTO Deadlines
Next Deadline
1540 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-09-26)
Due Date
September 26, 2029
Grace Period Ends
March 26, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
25 events| Date | Code | Type | Description |
|---|---|---|---|
| Sep 26, 2023 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
| Sep 26, 2023 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Aug 22, 2023 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Aug 22, 2023 | DP1B | I | 1(B) BASIS DELETED; PROCEED TO REGISTRATION |
| Jul 21, 2023 | D1BR | I | TEAS DELETE 1(B) BASIS RECEIVED |
| Jul 21, 2023 | IUCN | S | NOTICE OF ALLOWANCE CANCELLED |
| Jul 18, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| May 23, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION |
| May 23, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| May 3, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Apr 15, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Apr 14, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Apr 14, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Apr 13, 2023 | ALIE | A | ASSIGNED TO LIE |
| Jan 18, 2023 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Aug 4, 2022 | CNSI | R | SUSPENSION INQUIRY WRITTEN |
| Aug 4, 2022 | GNSI | S | INQUIRY TO SUSPENSION E-MAILED |
| Aug 4, 2022 | GNS2 | O | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED |
| Jul 8, 2022 | RCCK | S | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
| Dec 21, 2021 | CNSL | R | SUSPENSION LETTER WRITTEN |
| Dec 21, 2021 | GNSL | F | LETTER OF SUSPENSION E-MAILED |
| Dec 21, 2021 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Dec 17, 2021 | DOCK | D | ASSIGNED TO EXAMINER |
| Jul 30, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Apr 27, 2021 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 042
Research and development relating to drug substance and drug products for the pharmaceutical, biotech and vaccine sectors; evaluation relating to drug substance and drug products for the pharmaceutical, biotech and vaccine sectors; consultancy relating to drug substance and drug products for the pharmaceutical, biotech and vaccine sectors; testing relating to drug substance and drug products for the pharmaceutical, biotech and vaccine sectors; research and development of pharmaceutical, biotech and vaccine products; consultancy relating to pharmaceutical, biotech and vaccine sectors; advisory services relating to research and development of pharmaceutical, biotech and vaccine products
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
042